Vertex (VRTX) Offers Data from LT Follow-Up Study Showing Improvements in Lung Function with KALYDECO
Go back to Vertex (VRTX) Offers Data from LT Follow-Up Study Showing Improvements in Lung Function with KALYDECO| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 540.26 -11.8 (2.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $552.06 | 52 Week High | $134.71 | |||
| Open | $543.78 | 52 Week Low | $73.31 | |||
| Day High | $548.99 | P/E | N/A | |||
| Day Low | $538.27 | EPS | $-1.98 | |||
| Volume | 1,062,326 | |||||
